분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2012-10-29 20:50:08 , Hit : 2250
 Whitehead scientists identify major flaw in standard approach to global gene expression analysis

Public release date: 25-Oct-2012
[ Print | E-mail | Share ] [ Close Window ]

Contact: Nicole Rura
rura@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research



CAMBRIDGE, Mass. (October 25, 2012) –Whitehead Institute researchers report that common assumptions employed in the generation and interpretation of data from global gene expression analyses can lead to seriously flawed conclusions about gene activity and cell behavior in a wide range of current biological research.

"Expression analysis is one of the most commonly used methods in modern biology," says Whitehead Member Richard Young. "So we are concerned that flawed assumptions may affect the interpretation of many biological studies."

Much of today's interpretation of gene expression data relies on the assumption that all cells being analyzed have similar total amounts of messenger RNA (mRNA), the roughly 10% of a cell's RNA that acts as a blueprint for protein synthesis. However, some cells, including aggressive cancer cells, produce several times more mRNA than other cells. Traditional global gene expression analyses have typically ignored such differences.

"We've highlighted this common assumption in gene expression analysis that potentially affects many researchers," says Tony Lee, a scientist in Young's lab and a corresponding author of the article published in this week's issue of Cell. "We provided a concrete example of the problem and a solution that can be implemented by investigators."

Members of the Young lab recently uncovered the flaw while investigating genes expressed in cancer cells expressing high levels of c-Myc, a gene regulator known to be highly expressed in aggressive cancer cells. When comparing cells with high and low c-Myc levels, they were surprised to find very different results using different approaches to gene expression analysis. Further investigation revealed that there were striking differences in the total amounts of RNA from the high and low c-Myc -containing cells, yet these differences were masked by commonly used experimental and analytical methods.

"The different results we saw from different methods of gene expression analysis were shocking, and led us to reinvestigate the whole process on several platforms," says Jakob Lovén, postdoctoral reseacher in Young's lab and co-author of the Cell paper. "We then realized that the common assumption that cells contain similar levels of mRNA is badly flawed and can lead to serious misinterpretations, particularly with cancer cells that can have very different amounts of RNA."

In addition to delineating this problem, the Whitehead scientists also describe a remedy. By using synthetically produced mRNAs, called RNA spike-ins, as standardized controls, researchers can compare experimental data and eliminate assumptions about total cell RNA amounts. The remedy applies to all three gene expression analysis platforms they studied.

Although the researchers believe the use of RNA spike-ins should become the new standard for global gene expression analyses, questions are likely to persist about the interpretations of much prior research.

"There are over 750,000 expression datasets in public databases, and because they generally lack information about the cell numbers used in the analysis, it is unclear whether they can be re-examined in order to validate the original interpretation" says David Orlando, a scientist in the Young lab. "It may be necessary to reinvestigate some important concepts."

###

This work was supported by National Institutes of Health (NIH) grants HG002668 and CA146445, the American Cancer Society, and the Swedish Research Council.

Written by Nicole Giese Rura

Richard Young's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a professor of biology at Massachusetts Institute of Technology.

Full Citation:

"Revisiting Global Gene Expression Analysis"

Cell, in print October 26, 2012.

Jakob Lovén (1,5), David A. Orlando (1,5), Alla A. Sigova (1), Charles Y. Lin (1,2), Peter B. Rahl (1), Christopher B. Burge (3), David L. Levens (4), Tong Ihn Lee (1,5,*) and Richard A. Young (1,3,5)

1. Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA

2. Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

3. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

4. Gene Regulation Section, Laboratory of Pathology, National Cancer Institute, Center for Cancer Research, Bethesda, MD, 20892, USA

5. These authors contributed equally.








767   인간 게놈 백과사전 완성: 게놈은 유전자의 단순한 집합체가 아니다  이성욱 2012/09/10 2789
766   유전자 요법의 후각기능 회복  이성욱 2012/09/12 3157
765   “몸매는 날씬해야” 강박관념도 유전자 탓  이성욱 2012/10/04 2676
764   日 교토대, 쥐 유도만능줄기세포로 난자 만들어  이성욱 2012/10/06 3203
763   The Nobel Prize in Physiology or Medicine 2012  이성욱 2012/10/09 2575
762   Smallest and fastest-known RNA switches provide new drug targets  이성욱 2012/10/11 2489
761   Early-Earth cells modeled to show how first life forms might have packaged RNA  이성욱 2012/10/16 2585
760   유도만능줄기세포, 진짜 만능일까?  이성욱 2012/10/17 2717
759   Nobel work boosts drug development  이성욱 2012/10/23 2568
  Whitehead scientists identify major flaw in standard approach to global gene expression analysis  이성욱 2012/10/29 2250
757   유럽 첫 유전자 치료제 승인 지단백 리파제 결핍약 '글리베라' 허가  이성욱 2012/11/06 3978
756   CU-Boulder researchers uncover new target for cancer research  이성욱 2012/11/06 2756
755   Genomics: The single life  이성욱 2012/11/06 2131
754   Glybera Gains Official EMA Nod as First Gene Therapy  이성욱 2012/11/06 2683
753   술 퍼먹게 하는 유전자 있다  이성욱 2012/12/07 2887
752   Biopharma startup raises $51M for therapeutic to treat bleeding complications from angioplasty  이성욱 2012/12/22 2543
751   뇌의 신비 밝혀줄 지도가 만들어진다 - 올해는 휴먼 커넥톰 프로젝트가 완료되는 해  이성욱 2013/02/05 3532
750   Newly Identified Natural Protein Blocks HIV, Other Viruses  이성욱 2013/02/16 2284
749   'Activating' RNA takes DNA on a loop through time and space  이성욱 2013/02/19 2157
748   Electronics Giant Samsung Makes First Big Biotech Play  이성욱 2013/02/22 3202

[이전 10개] [1]..[21][22][23][24][25] 26 [27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN